Manulife closes $3.2 billion long-term-care reinsurance transaction

  • Manulife completed a long-term-care biometric-risk reinsurance transaction with Munich Re Life US.
  • $3.2 billion of reserves were covered at an 80% quota share.
  • The reinsurance took effect July 1, 2026, based on the June 30 position.

Manulife Financial Corporation has completed its previously announced transaction to reinsure biometric risk on a block of long-term care policies with C$3.2 billion in reserves to Munich American Reassurance Company, known as Munich Re Life US and a subsidiary of Munich Re Group. The reinsurance became effective July 1, 2026, and reflects an 80% quota share based on the IFRS 17 current estimate of the present value of future cash flows, risk adjustment and contractual service margin. Manulife, headquartered in Toronto, operates across 25 markets and served more than 37 million customers at the end of 2025. It had more than 37,000 employees, over 106,000 agents and thousands of distribution partners. The company operates as Manulife in Canada and Asia and primarily as John Hancock in the United States, while Manulife Wealth & Asset Management provides investment, advice and retirement services worldwide. Munich Re Life US is a U.S. reinsurer focused on life and disability reinsurance, digital transformation, financial reinsurance and merger-and-acquisition support.

本网站上的信息是使用AI生成的,我们无法保证其准确性。 请仅作为参考信息使用。